2023 Q3 Form 10-Q Financial Statement

#000110450623000018 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $79.07M $77.23M
YoY Change 16.75% 18.41%
Cost Of Revenue $16.71M $16.59M
YoY Change 24.01% 1.21%
Gross Profit $62.37M $60.64M
YoY Change 14.94% 24.19%
Gross Profit Margin 78.87% 78.51%
Selling, General & Admin $90.63M $84.43M
YoY Change 19.91% 40.78%
% of Gross Profit 145.32% 139.24%
Research & Development $109.1M $197.0M
YoY Change 9.29% 122.5%
% of Gross Profit 175.01% 324.84%
Depreciation & Amortization $3.430M $3.252M
YoY Change 32.18% 13.83%
% of Gross Profit 5.5% 5.36%
Operating Expenses $109.1M $282.7M
YoY Change 9.29% 219.3%
Operating Profit -$147.7M -$222.0M
YoY Change 15.64% 151.4%
Interest Expense $20.29M -$9.447M
YoY Change 505.07% -381.41%
% of Operating Profit
Other Income/Expense, Net $285.0K $696.0K
YoY Change -118.82% -116.16%
Pretax Income -$158.4M -$244.3M
YoY Change 21.12% 156.75%
Income Tax $500.0K $530.0K
% Of Pretax Income
Net Earnings -$158.9M -$244.8M
YoY Change 21.19% 155.96%
Net Earnings / Revenue -201.0% -316.99%
Basic Earnings Per Share -$1.11 -$1.78
Diluted Earnings Per Share -$1.11 -$1.78
COMMON SHARES
Basic Shares Outstanding 143.8M shares 136.4M shares
Diluted Shares Outstanding 142.9M shares 137.6M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $785.9M $917.8M
YoY Change 53.11% 65.39%
Cash & Equivalents $487.1M $612.9M
Short-Term Investments $298.8M $304.9M
Other Short-Term Assets $27.10M $26.36M
YoY Change 7.57% 12.84%
Inventory $77.92M $77.35M
Prepaid Expenses
Receivables $35.58M $30.95M
Other Receivables $0.00 $0.00
Total Short-Term Assets $926.6M $1.052B
YoY Change 46.57% 55.98%
LONG-TERM ASSETS
Property, Plant & Equipment $64.63M $100.9M
YoY Change 20.39% 87.09%
Goodwill $136.1M $136.1M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $92.50M $83.45M
YoY Change 45.19% 25.86%
Total Long-Term Assets $398.3M $386.7M
YoY Change 9.83% 2.14%
TOTAL ASSETS
Total Short-Term Assets $926.6M $1.052B
Total Long-Term Assets $398.3M $386.7M
Total Assets $1.325B $1.439B
YoY Change 33.18% 36.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $65.38M $58.79M
YoY Change 464.76% 88.76%
Accrued Expenses $125.7M $143.0M
YoY Change -0.03% 143.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.500M $2.445M
YoY Change 641.84% 1053.3%
Total Short-Term Liabilities $196.7M $204.3M
YoY Change 42.91% 79.46%
LONG-TERM LIABILITIES
Long-Term Debt $1.148B $1.168B
YoY Change 46.22% 49.01%
Other Long-Term Liabilities $5.918M $222.5M
YoY Change -47.81% 1446.52%
Total Long-Term Liabilities $1.153B $1.391B
YoY Change 44.88% 74.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $196.7M $204.3M
Total Long-Term Liabilities $1.153B $1.391B
Total Liabilities $1.614B $1.595B
YoY Change 57.52% 58.05%
SHAREHOLDERS EQUITY
Retained Earnings -$3.260B -$3.101B
YoY Change 28.53% 28.93%
Common Stock $1.430M $1.428M
YoY Change 17.5% 19.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$289.4M -$155.7M
YoY Change
Total Liabilities & Shareholders Equity $1.325B $1.439B
YoY Change 33.18% 36.62%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$158.9M -$244.8M
YoY Change 21.19% 155.96%
Depreciation, Depletion And Amortization $3.430M $3.252M
YoY Change 32.18% 13.83%
Cash From Operating Activities -$136.3M -$122.8M
YoY Change 51.77% 20.03%
INVESTING ACTIVITIES
Capital Expenditures $2.860M $4.883M
YoY Change -591.41% -268.15%
Acquisitions
YoY Change
Other Investing Activities $10.00M -$269.3M
YoY Change -80.0%
Cash From Investing Activities $7.140M -$274.2M
YoY Change -85.55% 9340.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.250M 44.33M
YoY Change -96.63% 602.36%
NET CHANGE
Cash From Operating Activities -136.3M -122.8M
Cash From Investing Activities 7.140M -274.2M
Cash From Financing Activities 1.250M 44.33M
Net Change In Cash -127.9M -352.6M
YoY Change 3784.03% 256.57%
FREE CASH FLOW
Cash From Operating Activities -$136.3M -$122.8M
Capital Expenditures $2.860M $4.883M
Free Cash Flow -$139.2M -$127.7M
YoY Change 55.96% 28.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.78
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.60
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14259000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
44241000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-244809000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2334000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7283000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38014000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
5000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
72390000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
4000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27082000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
44241000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
87951000 usd
us-gaap Net Income Loss
NetIncomeLoss
-404573000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2007000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8422000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38014000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
6000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
81640000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34802000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-155745000 usd
us-gaap Net Income Loss
NetIncomeLoss
-404573000 usd
us-gaap Net Income Loss
NetIncomeLoss
-190266000 usd
us-gaap Depreciation
Depreciation
2559000 usd
us-gaap Depreciation
Depreciation
2244000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2526000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2526000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
34802000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
27082000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3728000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1643000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
11201000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
3846000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
0 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1356000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1365000 usd
insm Noncash Operating Lease Expense
NoncashOperatingLeaseExpense
7299000 usd
insm Noncash Operating Lease Expense
NoncashOperatingLeaseExpense
9765000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
4000000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-24240000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-349000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6784000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
7458000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
224000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3558000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-5158000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-16533000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-269095000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-207462000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8281000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4605000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
292690000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
99706000 usd
insm Proceeds From Cash Acquired In Asset Acquisition
ProceedsFromCashAcquiredInAssetAcquisition
-3417000 usd
insm Proceeds From Cash Acquired In Asset Acquisition
ProceedsFromCashAcquiredInAssetAcquisition
0 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
65000000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-232554000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-104311000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8422000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13264000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
38014000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1291000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
494000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1218000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
43927000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12770000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3432000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1701000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-461154000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-300704000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1074036000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
716782000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
612882000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
416078000 usd
us-gaap Interest Paid Net
InterestPaidNet
19491000 usd
us-gaap Interest Paid Net
InterestPaidNet
5004000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1362000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1194000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
612900000 usd
CY2023Q2 us-gaap Marketable Securities
MarketableSecurities
304900000 usd
us-gaap Net Income Loss
NetIncomeLoss
-404600000 usd
us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates and judgments on historical experience and on various other assumptions. The amounts of assets and liabilities reported in the Company's balance sheets and the amounts of revenues and expenses reported for each period presented are affected by estimates and assumptions, which are used for, but not limited to, the accounting for revenue allowances, stock-based compensation, income taxes, loss contingencies, acquisition related intangibles including in process research and development (IPR&amp;D) and goodwill, fair value of contingent consideration, and accounting for research and development costs. Actual results could differ from those estimates.</span>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash equivalents with high credit-quality financial institutions and may invest its short-term investments in US treasury securities, mutual funds and government agency bonds. The Company has established guidelines relative to credit ratings and maturities that seek to maintain safety and liquidity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to risks associated with extending credit to customers related to the sale of products. The Company does not require collateral to secure amounts due from its customers. The Company uses an expected loss methodology to calculate allowances for trade receivables. The Company's measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company does not currently have a material allowance for uncollectible trade receivables. The following table presents the percentage of gross product revenue represented by the Company's three largest customers as of the six months ended June 30, 2023 and their respective percentages for the six months ended June 30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;padding-right:36pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.116%"><tr><td style="width:1.0%"></td><td style="width:33.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.934%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.717%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on third-party manufacturers and suppliers for manufacturing and supply of its products. The inability of the suppliers or manufacturers to fulfill supply requirements of the Company could materially impact future operating results. A change in the relationship with the suppliers or manufacturers, or an adverse change in their business, could materially impact future operating results.</span></div>
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 reportingunit
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 reportingunit
CY2023Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-244809000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-95645000 usd
us-gaap Net Income Loss
NetIncomeLoss
-404573000 usd
us-gaap Net Income Loss
NetIncomeLoss
-190266000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
137553000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119602000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
136957000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119267000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137553000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119602000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136957000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119267000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.78
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.78
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.80
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.60
CY2023Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
304900000 usd
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
300000 usd
CY2023Q2 insm Business Combination Deferred Liability
BusinessCombinationDeferredLiability
7800000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
77229000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65221000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142443000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118328000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
26900000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
27245000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
30331000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
22460000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
20118000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
20217000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
77349000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
69922000 usd
CY2023Q2 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P12Y
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5100000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5100000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5100000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5100000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5100000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
68756000 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2526000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
66230000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
73809000 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2526000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
71283000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
136100000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
136100000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
103995000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
95936000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41882000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
39445000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62113000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56491000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
55699000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
50461000 usd
CY2023Q2 insm Accrued Clinical Trial Expenses
AccruedClinicalTrialExpenses
33599000 usd
CY2022Q4 insm Accrued Clinical Trial Expenses
AccruedClinicalTrialExpenses
36456000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
19053000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
14403000 usd
CY2023Q2 insm Accrued Technical Operation Expenses
AccruedTechnicalOperationExpenses
7099000 usd
CY2022Q4 insm Accrued Technical Operation Expenses
AccruedTechnicalOperationExpenses
3345000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25151000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
32040000 usd
CY2023Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
6231000 usd
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
4710000 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
2176000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
6340000 usd
CY2023Q2 insm Royalty Revenue Payable
RoyaltyRevenuePayable
3089000 usd
CY2022Q4 insm Royalty Revenue Payable
RoyaltyRevenuePayable
2149000 usd
CY2023Q2 insm Accrued Sales Allowancesand Related Costs
AccruedSalesAllowancesandRelatedCosts
11077000 usd
CY2022Q4 insm Accrued Sales Allowancesand Related Costs
AccruedSalesAllowancesandRelatedCosts
6974000 usd
CY2023Q2 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
12895000 usd
CY2022Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
12943000 usd
CY2023Q2 insm Business Combination Deferred Payments Current
BusinessCombinationDeferredPaymentsCurrent
19200000 usd
CY2022Q4 insm Business Combination Deferred Payments Current
BusinessCombinationDeferredPaymentsCurrent
10700000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2384000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1596000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
197653000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
182117000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
4100000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1500000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
4200000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1600000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
9287000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
130000 usd
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
166000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1881000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
507000 usd
insm Lessee Operating Lease Lease Not Yet Commenced Amount
LesseeOperatingLeaseLeaseNotYetCommencedAmount
44500000 usd
CY2022 insm Lessee Operating Lease Lease Not Yet Commenced Amount
LesseeOperatingLeaseLeaseNotYetCommencedAmount
40700000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1139805000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1125250000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
11200000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
225000000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
182683000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
182683000 usd
CY2023Q2 insm Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
575000000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
1165366000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2004000 usd
CY2022Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
821000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3728000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1643000 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
354000 usd
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
0 usd
us-gaap Interest Income Other
InterestIncomeOther
427000 usd
us-gaap Interest Income Other
InterestIncomeOther
0 usd
CY2023Q2 insm Interest Expense Excluding Finance Lease Interest Expense
InterestExpenseExcludingFinanceLeaseInterestExpense
20007000 usd
CY2022Q2 insm Interest Expense Excluding Finance Lease Interest Expense
InterestExpenseExcludingFinanceLeaseInterestExpense
2883000 usd
insm Interest Expense Excluding Finance Lease Interest Expense
InterestExpenseExcludingFinanceLeaseInterestExpense
39396000 usd
insm Interest Expense Excluding Finance Lease Interest Expense
InterestExpenseExcludingFinanceLeaseInterestExpense
5768000 usd
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
612000 usd
CY2022Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
474000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1226000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
880000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
20619000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
3357000 usd
us-gaap Interest Expense
InterestExpense
40622000 usd
us-gaap Interest Expense
InterestExpense
6648000 usd
CY2023Q2 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
152020000 usd
CY2022Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
148015000 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
142750463 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
142750463 shares
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
20.00
CY2022Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
16200000 usd
CY2021Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
25.00
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17500000 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
insm Share Based Compensation Arrangement By Share Based Payment Award Inducement Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardInducementOptionsGrantsInPeriodGross
1299040 shares
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
2100000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1900000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
4300000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
3900000 usd
CY2023Q2 us-gaap Share Price
SharePrice
21.10
CY2023Q1 us-gaap Share Price
SharePrice
18.50
CY2021Q2 insm Business Acquisition Consecutive Trading Day Period
BusinessAcquisitionConsecutiveTradingDayPeriod
45 days
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001104506-23-000018-index-headers.html Edgar Link pending
0001104506-23-000018-index.html Edgar Link pending
0001104506-23-000018.txt Edgar Link pending
0001104506-23-000018-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
image_01.jpg Edgar Link pending
insm-20230630.htm Edgar Link pending
insm-20230630.xsd Edgar Link pending
insm-20230630ex1011.htm Edgar Link pending
insm-20230630ex1012.htm Edgar Link pending
insm-20230630ex1013.htm Edgar Link pending
insm-20230630ex1014.htm Edgar Link pending
insm-20230630ex1015.htm Edgar Link pending
insm-20230630ex1016.htm Edgar Link pending
insm-20230630ex1017.htm Edgar Link pending
insm-20230630ex311.htm Edgar Link pending
insm-20230630ex312.htm Edgar Link pending
insm-20230630ex321.htm Edgar Link pending
insm-20230630ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
insm-20230630_cal.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
insm-20230630_lab.xml Edgar Link unprocessable
insm-20230630_pre.xml Edgar Link unprocessable
insm-20230630_htm.xml Edgar Link completed
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
insm-20230630_def.xml Edgar Link unprocessable